OLD National Bancorp IN Has $26.70 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

OLD National Bancorp IN cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 50,979 shares of the healthcare conglomerate's stock after selling 3,464 shares during the quarter. UnitedHealth Group accounts for 0.7% of OLD National Bancorp IN's portfolio, making the stock its 24th largest position. OLD National Bancorp IN's holdings in UnitedHealth Group were worth $26,700,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. Geode Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares during the period. Capital International Investors increased its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the period. Norges Bank acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. Northern Trust Corp increased its holdings in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. increased its holdings in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH traded up $7.40 during mid-day trading on Friday, hitting $303.24. The company's stock had a trading volume of 12,558,756 shares, compared to its average volume of 7,009,546. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $275.08 billion, a PE ratio of 19.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.44. The stock's 50-day moving average is $409.03 and its two-hundred day moving average is $483.40.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the company posted $6.91 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Insider Buying and Selling

In other news, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.33% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on UNH shares. Raymond James downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Deutsche Bank Aktiengesellschaft dropped their price objective on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Robert W. Baird dropped their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Finally, Oppenheimer dropped their price objective on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $428.43.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.